Ararat Capital Management, LP Alnylam Pharmaceuticals, Inc. Transaction History

Ararat Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $4.62 Million - $6.07 Million	-28,985 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $108,979 - $133,362	642 Added 2.27%	28,985 $5.47 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $328,392 - $451,600	2,553 Added 9.9%	28,343 $4.81 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $3.17 Million - $3.79 Million	25,790 New	25,790 $3.35 Million

641

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Ararat Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Ararat Capital Management, LP with notifications on news.